Zobrazeno 1 - 10
of 39
pro vyhledávání: '"ICIAR AVILES-OLMOS"'
Autor:
Marie Miquel, Umberto Spampinato, Chrystelle Latxague, Iciar Aviles-Olmos, Benedikt Bader, Kelly Bertram, Kailash Bhatia, Pierre Burbaud, Lothar Burghaus, Jin Whan Cho, Emmanuel Cuny, Adrian Danek, Thomas Foltynie, Pedro J Garcia Ruiz, Santiago Giménez-Roldán, Dominique Guehl, Jorge Guridi, Marwan Hariz, Paul Jarman, Zinovia Maria Kefalopoulou, Patricia Limousin, Nir Lipsman, Andres M Lozano, Elena Moro, Dhita Ngy, Maria Cruz Rodriguez-Oroz, Huifang Shang, Hyeeun Shin, Ruth H Walker, Fusako Yokochi, Ludvic Zrinzo, François Tison
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79241 (2013)
Chorea-acanthocytosis (ChAc) is a neuroacanthocytosis syndrome presenting with severe movement disorders poorly responsive to drug therapy. Case reports suggest that bilateral deep brain stimulation (DBS) of the ventro-postero-lateral internal globus
Externí odkaz:
https://doaj.org/article/b3639619425f4447b2a4b9f8a1167f32
Publikováno v:
Parkinson's Disease, Vol 2012 (2012)
L-dopa is the most effective, currently available treatment for Parkinson’s disease (PD), but it leads to the development of involuntary movements known as L-dopa-induced dyskinesia (LID) in the majority of patients after long-term use. Both gene a
Externí odkaz:
https://doaj.org/article/d3f745f0e6f2423486c0552ce743f9b2
Publikováno v:
Parkinson's Disease, Vol 2011 (2011)
Neural cell transplantation and gene therapy have attracted considerable interest as promising therapeutic alternatives for patients with Parkinson's disease (PD). Preclinical and open-label studies have suggested that grafted fetal neural tissue or
Externí odkaz:
https://doaj.org/article/f71972d540294152b0fd4ed7163b2042
Autor:
Iciar Aviles‐Olmos, Jorge M. Núñez-Córdoba, Miguel Fernandez-Martinez, María Aranzazu Gorospe, Elena Cacho-Asenjo, Antonio Martinez-Simon, Cristina Honorato-Cia, Jorge Guridi, Maria C. Rodriguez-Oroz, Lain H. Gonzalez‐Quarante, Alfredo Panadero
Publikováno v:
Mov Disord Clin Pract
BACKGROUND: During magnetic resonance–guided focused ultrasound for essential or parkinsonian tremor, adverse events (headache, nausea/vomiting, or anxiety) may alter the outcome of the procedure despite being mostly transient and mild. OBJECTIVES:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa24f55fbf50b4596bfe9e7528cdad23
https://pubmed.ncbi.nlm.nih.gov/34307742
https://pubmed.ncbi.nlm.nih.gov/34307742
Autor:
Harith Akram, Brian L. Day, Amy Peters, Iciar Aviles-Olmos, Marwan Hariz, Ali Rajabian, Thomas Foltynie, Dorothy Cowie, Viswas Dayal, Patricia Limousin, Ludvic Zrinzo, Jonathan Hyam, Marjan Jahanshahi
Publikováno v:
Stereotactic and functional neurosurgery. 99(4)
Background: Deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) has been investigated for the treatment of levodopa-refractory gait dysfunction in parkinsonian disorders, with equivocal results so far. Objectives: To summarize the clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f78e5376130010338ec268febb39e0
https://pubmed.ncbi.nlm.nih.gov/33279909
https://pubmed.ncbi.nlm.nih.gov/33279909
Autor:
Luca Zampedri, Kate Maclagan, Thomas Foltynie, Kashfia Chowdhury, Iciar Aviles-Olmos, Simon S. Skene, Dilan Athauda, Patricia Limousin, Natalia Budnik, Steve Hibbert
Publikováno v:
Journal of Parkinson's Disease. 8:247-258
Background Exenatide is a GLP-1 receptor agonist that was recently studied for potential disease-modifying effects in a randomised, placebo-controlled clinical trial in patients with moderate stage Parkinson’s disease, and showed positive effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd3d5290492b19e86abb4fde87b2e12
https://doi.org/10.3233/jpd-181329
https://doi.org/10.3233/jpd-181329
Autor:
Nigel H. Greig, Dawn Letchford, Martha Bajwa-Joseph, Dilan Athauda, Simon S. Skene, Natalia Budnik, Iciar Aviles-Olmos, Luca Zampedri, Andrew J. Lees, Patricia Limousin, Yazhou Li, Thomas Foltynie, Kashfia Chowdhury, Kate Maclagan, Susan Tebbs, John Dickson, Thomas T. Warner, Steve Hibbert
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Summary Background Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has neuroprotective effects in preclinical models of Parkinson's disease. We investigated whether these effects would be apparent in a clinical trial. Methods In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cff283ed769261be295ea25196b748
https://doi.org/10.1016/s0140-6736(17)31585-4
https://doi.org/10.1016/s0140-6736(17)31585-4
Autor:
Dilan Athauda, Patricia Limousin, Amy Peters, Iciar Aviles-Olmos, Thomas Foltynie, Ludvic Zrinzo, Peter Brown, Marwan Hariz, Dejan Georgiev, Brian L. Day
Publikováno v:
Movement Disorders Clinical Practice. 4:105-110
Orthostatic tremor (OT) is a rare, disabling movement disorder characterized by the development of a high‐frequency tremor of the lower limbs and feelings of unsteadiness upon standing, which compel the patient to sit down or walk. Medical therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc5f8e7d770284a01cea9e8b3ee6489
https://doi.org/10.1002/mdc3.12345
https://doi.org/10.1002/mdc3.12345
Autor:
Patricia Limousin, Steve Hibbert, Simon S. Skene, Dilan Athauda, Luca Zampedri, Kate Maclagan, Natalia Budnik, Thomas Foltynie, Iciar Aviles-Olmos, Kashfia Chowdhury
Publikováno v:
The European journal of neuroscience. 49(3)
Exenatide, a glucagon-like peptide-1 agonist and a licensed treatment for Type 2 diabetes significantly reduced deterioration in motor symptoms in patients with Parkinson’s disease in a randomized, placebo-controlled trial. In addition, there were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::188ae5debf4224e984880caf732eef18
https://pubmed.ncbi.nlm.nih.gov/30070753
https://pubmed.ncbi.nlm.nih.gov/30070753
Autor:
Garcia-Ruiz, Pedro J., Sanz-Cartagena, Pilar, Martinez-Castrillo, Juan C., Ares-Pensado, Begona, ICIAR AVILES-OLMOS, Blazquez-Estrada, Marta, Fanjul-Arbos, Samira, Garcia-Caldentey, Juan, Gazulla, Jose, Gutierrez-Garcia, Javier, Huete-Anton, Begona, Lucas-Rodenas, Cesar, Rosario Luquin, M., Martinez-Torres, Irene, Medialdea-Natera, Pilar, Mendoza-Rodriguez, Amelia, Mir-Rivera, Pablo, Posada, Ignacio J., Ruiz-Martinez, Javier, Sanchez-Alonso, Pilar, Trejo-Gabriel Y Galan, Jose M., Vela, Lydia, Pena-Segura, Jose L.
Publikováno v:
REVISTA DE NEUROLOGIA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
ResearcherID
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
ResearcherID
Botulinum toxin type A (BTA) is a bacterial endotoxin, whose therapeutic use has had a dramatic impact on different neurological disorders, such as dystonia and spasticity.To analyze and summarize different questions about the use of BTA in our clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::181f4a34b1b2bdb091c08b77b19a89fd
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9211
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9211
